Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. - Zoccali,C.; Mallamaci,F.; Tripepi,G.; Benedetto,F.A.; Cutrupi,S.; Parlongo,S.; Malatino,L.S.; Bonanno,G.; Seminara,G.; Rapisarda,F.; Fatuzzo,P.; Buemi,M.; et al. (J Am Soc Nephrol, 2002)